Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CEL Pharmaceutical is a prominent healthcare organization headquartered in Nicosia, Cyprus, dedicated to the manufacturing, importation, and distribution of pharmaceutical products. Since its inception in 1991, the company has established itself as a key player in the Cypriot market, offering a diverse portfolio that includes prescription medicines, medical devices, and food supplements. CEL operates a state-of-the-art manufacturing facility that adheres to Good Manufacturing Practice (GMP) standards, ensuring high-quality production for both local and international markets. The company maintains strategic alliances with global pharmaceutical leaders, facilitating the commercialization of innovative therapies across therapeutic areas such as cardiology, gastroenterology, and neurology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CEL Chadjianastasi Pharmaceutical.